These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7043421)

  • 1. [Insulin and glucagon in the treatment of acute liver failure].
    Zielińska W; Jasiel M; Wojciechowicz G
    Pol Arch Med Wewn; 1981; 66(5-6):401-11. PubMed ID: 7043421
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis.
    Fehér J; Cornides A; Romány A; Kárteszi M; Szalay L; Gógl A; Picazo J
    J Hepatol; 1987 Oct; 5(2):224-31. PubMed ID: 3320181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure.
    Harrison PM; Hughes RD; Forbes A; Portmann B; Alexander GJ; Williams R
    J Hepatol; 1990 May; 10(3):332-6. PubMed ID: 2195108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is guaranteed in the therapy of alcoholic hepatitis?].
    Seitz HK; Simanowski UA
    Internist (Berl); 1993 Jan; 34(1):30-4. PubMed ID: 8440572
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients.
    Baker AL; Jaspan JB; Haines NW; Hatfield GE; Krager PS; Schneider JF
    Gastroenterology; 1981 Jun; 80(6):1410-4. PubMed ID: 7014349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial.
    Bird G; Lau JY; Koskinas J; Wicks C; Williams R
    Hepatology; 1991 Dec; 14(6):1097-101. PubMed ID: 1959860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocyte pathology in viral and toxic injuries to the liver].
    Kartashova OIa; Terent'eva LA; Zaltsmane VK; Maksimova LA
    Vestn Akad Med Nauk SSSR; 1983; (11):74-81. PubMed ID: 6362270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine].
    De Pergola E; Carrozzini B; Selvaggio G; De Pergola G
    Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and glucagon therapy for alcoholic hepatitis.
    Maddrey WC
    Gastroenterology; 1981 Jun; 80(6):1596-8. PubMed ID: 7014353
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of insulin and glucagon on fulminant murine hepatitis.
    Farivar M; Wands JR; Isselbacher KJ; Bucher NL
    N Engl J Med; 1976 Dec; 295(27):1517-9. PubMed ID: 995158
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunohistochemical studies on the occurrence of HBs antigen in alcoholic fatty liver and alcoholic fatty liver hepatitis].
    Thaler H; Beham A
    Wien Klin Wochenschr; 1986 Mar; 98(5):151-5. PubMed ID: 3515768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotrophic factors: basic concepts and clinical implications.
    Baker AL
    Acta Med Scand Suppl; 1985; 703():201-8. PubMed ID: 3911740
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-pathological study of the therapeutic efficiency of carbamizole in the treatment of human alcoholic hepatitis].
    Sánchez Lombraña JL; Pérez R; Rodrigo L; González M; Saavedra LG; Linares A; Arce D
    Rev Esp Enferm Apar Dig; 1984 Mar; 65(3):233-8. PubMed ID: 6729186
    [No Abstract]   [Full Text] [Related]  

  • 15. [The protective effects of glucagon and insulin in an experimental massive hepatic cell necrosis model].
    Kuboi H; Mizoguchi Y; Kawada N; Sakaguchi H; Seki S; Kobayashi K; Morisawa S
    Nihon Shokakibyo Gakkai Zasshi; 1990 Feb; 87(2):211-7. PubMed ID: 2182924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adaptive and compensatory reactions in the liver].
    Blüger A; Kartaschowa O; Terentjewa L; Saldava L; Zalcmane V; Maksimowa L; Rudens J; Schill H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(2):68-75. PubMed ID: 4006841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biopsy study of chronic alcoholic hepatopathies. Assessment of the steatosis in the course of arginine thiazolidinecarboxylate treatment].
    Mauro G; Vigiani L
    Clin Ter; 1982 Feb; 100(4):359-74. PubMed ID: 7083785
    [No Abstract]   [Full Text] [Related]  

  • 18. [Theoretical background of insulin-glucagon therapy in liver failure].
    Hattori N; Noda Y; Tanaka N; Miyagoshi H; Noto Y; Kato H; Kobayashi K
    Nihon Rinsho; 1982; 40(4):831-6. PubMed ID: 7047801
    [No Abstract]   [Full Text] [Related]  

  • 19. A trial of glucagon in fulminant hepatitis.
    Narendranathan M; Nandini KK; Balakrishnan V
    J Assoc Physicians India; 1985 Mar; 33(3):219-20. PubMed ID: 4044480
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of acute alcoholic alcoholism].
    Michel H; Larrey D; Blanc P
    Ann Gastroenterol Hepatol (Paris); 1993; 29(1):29-39. PubMed ID: 7680191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.